Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Silence Therapeutics (SLN) Gross Profit: 2019-2024

Historic Gross Profit for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $31.4 million.

  • Silence Therapeutics' Gross Profit rose 104.44% to $95,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $23.6 million, marking a year-over-year increase of 319.24%. This contributed to the annual value of $31.4 million for FY2024, which is 67.49% up from last year.
  • Latest data reveals that Silence Therapeutics reported Gross Profit of $31.4 million as of FY2024, which was up 67.49% from $18.8 million recorded in FY2023.
  • Silence Therapeutics' Gross Profit's 5-year high stood at $31.4 million during FY2024, with a 5-year trough of $2.2 million in FY2020.
  • Its 3-year average for Gross Profit is $19.5 million, with a median of $18.8 million in 2023.
  • Per our database at Business Quant, Silence Therapeutics' Gross Profit surged by 607.72% in 2020 and then fell by 20.06% in 2022.
  • Over the past 5 years, Silence Therapeutics' Gross Profit (MRY) stood at $2.2 million in 2020, then skyrocketed by 209.45% to $6.8 million in 2021, then increased by 20.06% to $8.2 million in 2022, then surged by 129.20% to $18.8 million in 2023, then skyrocketed by 67.49% to $31.4 million in 2024.
  • Its last three reported values are $31.4 million in FY2024, $18.8 million for FY2023, and $8.2 million during FY2022.